CVS Health Stock Price, News & Analysis (NYSE:CVS)

$79.35 -0.15 (-0.19 %)
(As of 01/19/2018 02:42 AM ET)
Previous Close$79.50
Today's Range$79.26 - $80.69
52-Week Range$66.45 - $84.00
Volume8.07 million shs
Average Volume8.78 million shs
Market Capitalization$80.38 billion
P/E Ratio16.39
Dividend Yield2.52%
Beta0.9

About CVS Health (NYSE:CVS)

CVS Health logoCVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Retailers
Sub-IndustryDrug Retail
SectorNon-Cyclical Consumer Goods & Services
SymbolNYSE:CVS
CUSIP12665010
Phone+1-401-7651500

Debt

Debt-to-Equity Ratio0.67%
Current Ratio1.05%
Quick Ratio0.55%

Price-To-Earnings

Trailing P/E Ratio16.3946280991736
Forward P/E Ratio13.47
P/E Growth1.25

Sales & Book Value

Annual Sales$177.53 billion
Price / Sales0.45
Cash Flow$8.22 per share
Price / Cash9.65
Book Value$34.54 per share
Price / Book2.30

Profitability

Trailing EPS$4.84
Net Income$5.32 billion
Net Margins2.77%
Return on Equity16.96%
Return on Assets6.36%

Miscellaneous

Employees250,000
Outstanding Shares1,012,990,000

CVS Health (NYSE:CVS) Frequently Asked Questions

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health announced a quarterly dividend on Friday, December 29th. Shareholders of record on Wednesday, January 24th will be paid a dividend of $0.50 per share on Friday, February 2nd. This represents a $2.00 annualized dividend and a yield of 2.52%. The ex-dividend date is Tuesday, January 23rd. View CVS Health's Dividend History.

How were CVS Health's earnings last quarter?

CVS Health Corp (NYSE:CVS) released its quarterly earnings data on Monday, November, 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, topping analysts' consensus estimates of $1.49 by $0.01. The pharmacy operator had revenue of $46.18 billion for the quarter, compared to analyst estimates of $46.17 billion. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The firm's revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the previous year, the business posted $1.64 EPS. View CVS Health's Earnings History.

When will CVS Health make its next earnings announcement?

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, February, 7th 2018. View Earnings Estimates for CVS Health.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health updated its fourth quarter earnings guidance on Monday, November, 6th. The company provided EPS guidance of $1.88-1.92 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.91.

Where is CVS Health's stock going? Where will CVS Health's stock price be in 2018?

20 brokerages have issued 12-month price targets for CVS Health's stock. Their forecasts range from $73.00 to $106.67. On average, they anticipate CVS Health's stock price to reach $87.77 in the next twelve months. View Analyst Ratings for CVS Health.

What are Wall Street analysts saying about CVS Health stock?

Here are some recent quotes from research analysts about CVS Health stock:

  • 1. Guggenheim analysts commented, " Our recent meetings with CEO Larry Merlo, CFO Dave Denton, and VP-IR Nancy Christal further reinforced our confidence in 10% secular growth, which we believe the market is currently undervaluing, at a 13x P/E on somewhat depressed 2017E EPS. Bottom line, even in the face of secular gross margin erosion, in both segments, we believe the company should be able to grow EBIT by 5% on the back of a) natural growth in specialty Rx, b) increasingly rapid product innovation, c) a broadening set of productive relationships, and d) both COGS and SG&A reductions. In our view, this growth merits a valuation closer to a market multiple'we reiterate our Buy rating and $90 PT, implying 15% upside from current levels." (3/28/2017)
  • 2. Evercore ISI analysts commented, "While the quarter proved generally uneventful and guidance was reiterated on the surface (albeit some moving parts below ' dollar profit targets were unchanged in our view ' much of the delta related to where 4Q came out vs mid-point and lower inflation outlook), investors have reacted negatively to the lack of clarity on several key issues with respect to business model risk that in our minds is unlikely to dissipate until later in the year. We think management did an admirable job on the DIR fee issue and a reasonable job on gross to net / rebates, but the reality is that policy noise is unlikely to dissipate and the outlook for 2018 won't start to gain clarity until the summer. We think once we get initial color on the PBM selling season, a better understanding of underlying pharmacy share shifts and profit headwinds and ultimately gain a better picture of 2018 the multiple may start to see some relief. Until then CVS shares remain inexpensive and highly leveraged to tax reform and it appears as if many years of execution are being overshadowed by a tough 18 month stretch. Given how far shares have fallen and in our view strong FCF yield support we retain our Buy rating but acknowledge the path to returns from here is likely most appropriate for those with a multi-year time horizon and a 'deep value' focus." (2/9/2017)

Are investors shorting CVS Health?

CVS Health saw a increase in short interest in December. As of December 29th, there was short interest totalling 32,959,903 shares, an increase of 5.5% from the December 15th total of 31,227,273 shares. Based on an average trading volume of 7,767,991 shares, the days-to-cover ratio is currently 4.2 days. Currently, 3.3% of the shares of the company are short sold.

Who are some of CVS Health's key competitors?

Who are CVS Health's key executives?

CVS Health's management team includes the folowing people:

  • David Wyatt Dorman, Independent Chairman of the Board (Age 63)
  • Larry J. Merlo, President, Chief Executive Officer, Director (Age 61)
  • David M. Denton, Chief Financial Officer, Executive Vice President (Age 52)
  • Jonathan C. Roberts, Chief Operating Officer, Executive Vice President (Age 61)
  • Lisa G. Bisaccia, Chief Human Resource Officer, Executive Vice President (Age 61)
  • Stephen J. Gold, Executive Vice President, Chief Information Officer (Age 57)
  • Thomas M. Moriarty, Executive Vice President, General Counsel, Chief Health Strategy Officer (Age 53)
  • Troyen A. Brennan M.D., Executive Vice President, Chief Medical Officer (Age 62)
  • Helena B. Foulkes, Executive Vice President, President of CVS - Pharmacy (Age 52)
  • J. David Joyner, Executive Vice President (Age 52)

Who owns CVS Health stock?

CVS Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include Bank of Montreal Can (0.57%), Schwab Charles Investment Management Inc. (0.43%), Hexavest Inc. (0.13%), Factory Mutual Insurance Co. (0.13%), DnB Asset Management AS (0.12%) and CGOV Asset Management (0.11%). Company insiders that own CVS Health stock include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Stephen J Gold, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

Who sold CVS Health stock? Who is selling CVS Health stock?

CVS Health's stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, LVM Capital Management Ltd. MI, Factory Mutual Insurance Co., Edge Wealth Management LLC, Pennsylvania Trust Co, Trust Department MB Financial Bank N A, First Citizens Bank & Trust Co. and Endurance Wealth Management Inc.. Company insiders that have sold CVS Health company stock in the last year include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

Who bought CVS Health stock? Who is buying CVS Health stock?

CVS Health's stock was bought by a variety of institutional investors in the last quarter, including DnB Asset Management AS, Hexavest Inc., USS Investment Management Ltd, Alta Capital Management LLC, Franklin Street Advisors Inc. NC, Schwab Charles Investment Management Inc., CGOV Asset Management and Wasatch Advisors Inc.. View Insider Buying and Selling for CVS Health.

How do I buy CVS Health stock?

Shares of CVS Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS Health stock can currently be purchased for approximately $79.35.

How big of a company is CVS Health?

CVS Health has a market capitalization of $80.38 billion and generates $177.53 billion in revenue each year. The pharmacy operator earns $5.32 billion in net income (profit) each year or $4.84 on an earnings per share basis. CVS Health employs 250,000 workers across the globe.

How can I contact CVS Health?

CVS Health's mailing address is 1 Cvs Dr, WOONSOCKET, RI 02895-6146, United States. The pharmacy operator can be reached via phone at +1-401-7651500 or via email at [email protected]


MarketBeat Community Rating for CVS Health (CVS)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  905 (Vote Outperform)
Underperform Votes:  405 (Vote Underperform)
Total Votes:  1,310
MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

CVS Health (NYSE:CVS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.702.632.672.63
Ratings Breakdown: 0 Sell Rating(s)
7 Hold Rating(s)
12 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $87.77$86.10$89.82$94.27
Price Target Upside: 10.41% upside20.10% upside21.21% upside20.97% upside

CVS Health (NYSE:CVS) Consensus Price Target History

Price Target History for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/18/2018CowenReiterated RatingOutperform$81.00 -> $99.00LowView Rating Details
1/8/2018Leerink SwannBoost Price TargetOutperform -> Outperform$82.00 -> $90.00LowView Rating Details
1/5/2018SunTrust BanksBoost Price TargetBuy$90.00HighView Rating Details
1/5/2018Morgan StanleyUpgradeEqual Weight -> Overweight$88.00HighView Rating Details
1/4/2018Raymond James FinancialUpgradeOutperform -> Strong-Buy$90.00HighView Rating Details
1/2/2018Needham & Company LLCBoost Price TargetBuy$85.00 -> $88.00MediumView Rating Details
12/26/2017Tigress FinancialReiterated RatingBuyLowView Rating Details
12/5/2017Deutsche BankReiterated RatingBuy -> HoldMediumView Rating Details
12/4/2017Royal Bank of CanadaSet Price TargetBuy$95.00LowView Rating Details
12/4/2017Robert W. BairdSet Price TargetHold$77.00MediumView Rating Details
12/4/2017Jefferies GroupSet Price TargetHold$76.00MediumView Rating Details
12/4/2017Loop CapitalSet Price TargetHold$73.00MediumView Rating Details
12/4/2017CitigroupSet Price TargetHold$76.00MediumView Rating Details
10/24/2017MizuhoSet Price TargetBuy$90.00N/AView Rating Details
10/9/2017OppenheimerReiterated RatingBuy$95.00N/AView Rating Details
8/14/2017Wolfe ResearchDowngradeOutperform -> Market Perform$89.00 -> $82.00LowView Rating Details
7/3/2017GuggenheimReiterated RatingBuyLowView Rating Details
5/3/2017Evercore ISIReiterated RatingOutperform$87.00 -> $88.00LowView Rating Details
2/28/2017Bank of AmericaReiterated RatingBuy$106.67N/AView Rating Details
2/6/2017Atlantic SecuritiesDowngradeOverweight -> Neutral$84.00N/AView Rating Details
12/19/2016Credit Suisse GroupReiterated RatingBuyN/AView Rating Details
11/10/2016ArgusReiterated RatingBuy$120.00 -> $85.00N/AView Rating Details
11/9/2016BarclaysReiterated RatingBuy$85.00N/AView Rating Details
8/3/2016FBR & CoReiterated RatingOutperform$120.00N/AView Rating Details
5/5/2016MacquarieReiterated RatingOutperform$115.00N/AView Rating Details
2/10/2016Goldman Sachs GroupBoost Price TargetNeutral$106.00 -> $110.00N/AView Rating Details
(Data available from 1/19/2016 forward)

Earnings

CVS Health (NYSE:CVS) Earnings History and Estimates Chart

Earnings by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE CVS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2018N/AView Earnings Details
11/6/2017Q3 2017$1.49$1.50$46.17 billion$46.18 billionViewN/AView Earnings Details
8/8/2017Q2 2017$1.31$1.33$45.36 billion$45.69 billionViewListenView Earnings Details
5/2/2017Q1 2017$1.10$1.17$44.20 billion$44.51 billionViewListenView Earnings Details
2/9/2017Q416$1.67$1.71$46.56 billion$46.00 billionViewListenView Earnings Details
11/8/2016Q316$1.57$1.64$45.29 billion$44.60 billionViewListenView Earnings Details
8/2/2016Q216$1.30$1.32$44.28 billion$43.70 billionViewN/AView Earnings Details
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details
2/10/2015Q414$1.21$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details
11/6/2012Q312$0.84$0.85$30.09 billion$30.23 billionViewN/AView Earnings Details
8/7/2012$0.80$0.81ViewN/AView Earnings Details
5/2/2012$0.63$0.65ViewN/AView Earnings Details
2/8/2012Q4 2011$0.89$0.89ViewN/AView Earnings Details
11/3/2011$0.68$0.70ViewN/AView Earnings Details
8/4/2011$0.65$0.65ViewN/AView Earnings Details
5/5/2011$0.55$0.57ViewN/AView Earnings Details
2/3/2011$0.79$0.80ViewN/AView Earnings Details
11/3/2010Q3 2010$0.64$0.65ViewN/AView Earnings Details
7/28/2010Q2 2010$0.68$0.65ViewN/AView Earnings Details
5/4/2010Q1 2010$0.58$0.60ViewN/AView Earnings Details
2/8/2010Q4 2009$0.78$0.79ViewN/AView Earnings Details
11/5/2009Q3 2009$0.64$0.65ViewN/AView Earnings Details
8/4/2009Q2 2009$0.64$0.65ViewN/AView Earnings Details
5/5/2009Q1 2009$0.54$0.55ViewN/AView Earnings Details
2/19/2009Q4 2008$0.69$0.70ViewN/AView Earnings Details
10/30/2008Q3 2008$0.59$0.60ViewN/AView Earnings Details
7/31/2008Q2 2008$0.60$0.60ViewN/AView Earnings Details
5/1/2008Q1 2008$0.54$0.55ViewN/AView Earnings Details
1/31/2008Q4 2007$0.55$0.58ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

CVS Health (NYSE:CVS) Earnings Estimates

2018 EPS Consensus Estimate: $6.57
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185$1.10$1.49$1.28
Q2 20185$1.43$1.63$1.56
Q3 20184$1.44$1.91$1.72
Q4 20184$1.97$2.07$2.01
Q1 20192$1.11$1.24$1.18
Q2 20192$1.32$1.59$1.46
Q3 20191$1.56$1.56$1.56
(Earnings estimates data provided by Zacks Investment Research)

Dividends

CVS Health (NYSE:CVS) Dividend Information

Next Dividend:2/2/2018
Annual Dividend:$2.00
Dividend Yield:2.52%
Dividend Growth:22.10% (3 Year Average)
Payout Ratio:41.32% (Trailing 12 Months of Earnings)
33.96% (Based on This Year's Estimates)
31.01% (Based on Next Year's Estimates)
Track Record:10 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/29/2017quarterly$0.502.72%1/23/20181/24/20182/2/2018
9/19/2017quarterly$0.502.48%10/23/201710/24/201711/3/2017
7/6/2017quarterly$0.502.54%7/20/20177/24/20178/3/2017
3/2/2017quarterly$0.502.47%4/19/20174/21/20175/1/2017
12/22/2016quarterly$0.502.54%1/20/20171/24/20172/2/2017
9/22/2016quarterly$0.431.88%10/20/201610/24/201611/3/2016
7/6/2016quarterly$0.431.78%7/19/20167/21/20168/1/2016
3/2/2016quarterly$0.431.71%4/20/20164/22/20165/2/2016
12/16/2015quarterly$0.431.79%1/20/20161/22/20162/2/2016
10/1/2015quarterly$0.351.41%10/20/201510/22/201511/2/2015
7/8/2015quarterly$0.351.32%7/21/20157/23/20158/3/2015
3/4/2015quarterly$0.351.35%4/22/20154/24/20155/4/2015
12/17/2014quarterly$0.351.49%1/20/20151/22/20152/2/2015
9/24/2014quarterly$0.281.38%10/21/201410/23/201411/3/2014
7/10/2014quarterly$0.281.43%7/17/20147/21/20148/1/2014
3/6/2014quarterly$0.281.5%4/17/20144/22/20145/2/2014
12/18/2013quarterly$0.281.57%1/21/20141/23/20142/3/2014
9/25/2013quarterly$0.231.55%10/17/201310/21/201311/1/2013
7/10/2013quarterly$0.231.48%7/18/20137/22/20138/2/2013
3/6/2013quarterly$0.231.73%4/19/20134/23/20135/3/2013
12/13/2012quarterly$0.231.83%1/22/20131/24/20132/4/2013
(Data available from 1/1/2013 forward)

Insider Trades

CVS Health (NYSE CVS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.61%
Institutional Ownership Percentage: 81.69%
Insider Trades by Quarter for CVS Health (NYSE:CVS)
Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE CVS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/21/2017Lisa BisacciaEVPSell29,445$75.00$2,208,375.0015,556View SEC Filing  
10/2/2017Thomas M MoriartyEVPSell20,547$81.17$1,667,799.9943,178View SEC Filing  
9/18/2017Jonathan C RobertsCOOSell85,743$83.14$7,128,673.02119,555View SEC Filing  
9/15/2017Helena FoulkesEVPSell39,340$81.88$3,221,159.2084,337View SEC Filing  
9/13/2017Larry J MerloInsiderSell241,150$83.07$20,032,330.50299,255View SEC Filing  
9/11/2017David M DentonCFOSell237,078$79.65$18,883,262.70141,096View SEC Filing  
9/11/2017Thomas M MoriartyEVPSell90,267$79.61$7,186,155.8770,102View SEC Filing  
8/16/2017Richard J SwiftDirectorSell2,500$79.62$199,050.003,258View SEC Filing  
6/26/2017Helena FoulkesEVPSell20,333$80.00$1,626,640.0059,301View SEC Filing  
6/19/2017Helena FoulkesEVPSell20,332$76.98$1,565,157.3659,300View SEC Filing  
6/12/2017David M DentonCFOSell230,510$80.00$18,440,800.00176,983View SEC Filing  
3/21/2017Troyen A BrennanEVPSell23,849$78.73$1,877,631.7794,309View SEC Filing  
3/17/2017Eva C BorattoEVPSell6,029$79.60$479,908.4041,614View SEC Filing  
3/13/2017Andrew SussmanEVPSell14,104$80.40$1,133,961.6022,801View SEC Filing  
3/10/2017David M DentonCFOSell95,618$80.68$7,714,460.24250,335View SEC Filing  
2/16/2017Jonathan C RobertsEVPSell61,196$80.00$4,895,680.0089,955View SEC Filing  
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00280,381View SEC Filing  
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.0069,601View SEC Filing  
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.0042,048View SEC Filing  
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00261,287View SEC Filing  
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.3075,315View SEC Filing  
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02561,059View SEC Filing  
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00161,613View SEC Filing  
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.0043,858View SEC Filing  
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.086,998View SEC Filing  
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.1156,187View SEC Filing  
1/3/2014David DentonCFOSell14,113$70.50$994,966.5085,869View SEC Filing  
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52219,871View SEC Filing  
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.1240,563View SEC Filing  
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00408,649View SEC Filing  
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.0027,233View SEC Filing  
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.0756,187View SEC Filing  
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.5019,448View SEC Filing  
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.007,897View SEC Filing  
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.203,128View SEC Filing  
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

CVS Health (NYSE CVS) News Headlines

Source:
DateHeadline
CVS looks to ban airbrushing in adsCVS looks to ban airbrushing in ads
finance.yahoo.com - January 18 at 4:25 PM
CVS Health Grows in PBM With Rheumatoid Arthritis ProgramCVS Health Grows in PBM With Rheumatoid Arthritis Program
finance.yahoo.com - January 18 at 10:54 AM
Walmart offers free opioid disposal product in effort to fight painkiller-abuse epidemicWalmart offers free opioid disposal product in effort to fight painkiller-abuse epidemic
finance.yahoo.com - January 17 at 5:01 PM
 Analysts Anticipate CVS Health Corp (CVS) to Announce $1.89 Earnings Per Share Analysts Anticipate CVS Health Corp (CVS) to Announce $1.89 Earnings Per Share
www.americanbankingnews.com - January 17 at 11:36 AM
Is CVS Health Corporation a Buy in 2018?Is CVS Health Corporation a Buy in 2018?
finance.yahoo.com - January 17 at 9:51 AM
Walmart Takes on the Opioid Crisis With a New Tool That Destroys DrugsWalmart Takes on the Opioid Crisis With a New Tool That Destroys Drugs
finance.yahoo.com - January 17 at 9:51 AM
Walmart offers free opioid disposal product in effort to fight painkiller abuse epidemicWalmart offers free opioid disposal product in effort to fight painkiller abuse epidemic
finance.yahoo.com - January 17 at 9:51 AM
CVS Health Launches New Transform Rheumatoid Arthritis Care™ Program to Improve Clinical Outcomes and Lower Pharmacy CostsCVS Health Launches New Transform Rheumatoid Arthritis Care™ Program to Improve Clinical Outcomes and Lower Pharmacy Costs
finance.yahoo.com - January 17 at 9:51 AM
5 Reasons Why McKesson Deserves a Place in Your Portfolio5 Reasons Why McKesson Deserves a Place in Your Portfolio
finance.yahoo.com - January 17 at 9:51 AM
CVS Is Making a Big Change in the Beauty AisleCVS Is Making a Big Change in the Beauty Aisle
finance.yahoo.com - January 16 at 4:54 PM
CVS Photoshopping Ban: Some Beauty Ads Won’t Be Digitally AlteredCVS Photoshopping Ban: Some Beauty Ads Won’t Be Digitally Altered
finance.yahoo.com - January 16 at 4:54 PM
CVS Takes Up Beauty Image Transparency MantleCVS Takes Up Beauty Image Transparency Mantle
finance.yahoo.com - January 16 at 4:54 PM
CVS is on a mission to make beauty advertising more realisticCVS is on a mission to make beauty advertising more realistic
finance.yahoo.com - January 16 at 4:54 PM
10 Cheap Stocks With Growing Dividends10 Cheap Stocks With Growing Dividends
finance.yahoo.com - January 16 at 9:59 AM
CVS Health Corp (CVS) Short Interest Up 5.5% in DecemberCVS Health Corp (CVS) Short Interest Up 5.5% in December
www.americanbankingnews.com - January 16 at 3:32 AM
CVS Pharmacy promises to end touchups of its beauty imagesCVS Pharmacy promises to end touchups of its beauty images
marketbeat.com - January 15 at 5:35 PM
CVS Pharmacy promises to end touch ups of its beauty imagesCVS Pharmacy promises to end touch ups of its beauty images
marketbeat.com - January 15 at 10:38 AM
CVS Pharmacy Makes Commitment to Create New Standards for Post-Production Alterations of Beauty ImageryCVS Pharmacy Makes Commitment to Create New Standards for Post-Production Alterations of Beauty Imagery
finance.yahoo.com - January 15 at 9:51 AM
CVS Vows to Stop Altering Beauty Images in Its MarketingCVS Vows to Stop Altering Beauty Images in Its Marketing
finance.yahoo.com - January 15 at 9:51 AM
CVS to Keep Aetna in Hartford, Conn.CVS to Keep Aetna in Hartford, Conn.
www.wsj.com - January 12 at 4:44 PM
Bill Nygren Comments on CVS Health CorpBill Nygren Comments on CVS Health Corp
finance.yahoo.com - January 12 at 4:44 PM
[$$] CVS to Keep Aetna in Hartford, Conn.[$$] CVS to Keep Aetna in Hartford, Conn.
finance.yahoo.com - January 12 at 4:44 PM
CVS-Aetna Deal Could Heighten Experiential Retail - Seeking AlphaCVS-Aetna Deal Could Heighten Experiential Retail - Seeking Alpha
seekingalpha.com - January 12 at 10:02 AM
NEW AGE BEVERAGES CORPORATION EXPANDS XINGTEA BRAND WITH CVS HEALTH THROUGHOUT THE ... - GlobeNewswire (press release)NEW AGE BEVERAGES CORPORATION EXPANDS XINGTEA BRAND WITH CVS HEALTH THROUGHOUT THE ... - GlobeNewswire (press release)
globenewswire.com - January 12 at 10:02 AM
[$$] New York City Halts Incentive Package for Aetna Headquarters[$$] New York City Halts Incentive Package for Aetna Headquarters
finance.yahoo.com - January 11 at 10:17 AM
Wall Street’s Take on Rite Aid after 3Q17 ResultsWall Street’s Take on Rite Aid after 3Q17 Results
finance.yahoo.com - January 11 at 10:17 AM
Walgreens Beats 1Q18 Earnings Expectations, Lifts GuidanceWalgreens Beats 1Q18 Earnings Expectations, Lifts Guidance
finance.yahoo.com - January 11 at 10:17 AM
Rite Aid’s 3Q17 Results: A Quick LookRite Aid’s 3Q17 Results: A Quick Look
finance.yahoo.com - January 10 at 10:05 AM
Consumer Sector Insights for the First Week of 2018Consumer Sector Insights for the First Week of 2018
finance.yahoo.com - January 10 at 10:05 AM
Major Mergers and Acquisitions in December: What Investors Should Know About CVS, Disney, Apple and MoreMajor Mergers and Acquisitions in December: What Investors Should Know About CVS, Disney, Apple and More
www.msn.com - January 9 at 4:57 PM
Equities Analysts Issue Forecasts for CVS Health Corps FY2017 Earnings (CVS)Equities Analysts Issue Forecasts for CVS Health Corp's FY2017 Earnings (CVS)
www.americanbankingnews.com - January 9 at 7:28 AM
CVS-Aetna Kicks Off Retails Hunt for InsurersCVS-Aetna Kicks Off Retail's Hunt for Insurers
finance.yahoo.com - January 8 at 5:00 PM
Leerink Swann Raises CVS Health (CVS) Price Target to $90.00Leerink Swann Raises CVS Health (CVS) Price Target to $90.00
www.americanbankingnews.com - January 8 at 10:26 AM
How Medicare Makes Rite Aid A Buyout TargetHow Medicare Makes Rite Aid A Buyout Target
finance.yahoo.com - January 8 at 9:24 AM
Q4 2017 EPS Estimates for CVS Health Corp Cut by Oppenheimer (CVS)Q4 2017 EPS Estimates for CVS Health Corp Cut by Oppenheimer (CVS)
www.americanbankingnews.com - January 8 at 3:54 AM
FY2017 Earnings Estimate for CVS Health Corp Issued By SunTrust Banks (CVS)FY2017 Earnings Estimate for CVS Health Corp Issued By SunTrust Banks (CVS)
www.americanbankingnews.com - January 8 at 2:56 AM
Raymond James Financial Upgrades CVS Health (CVS) to Strong-BuyRaymond James Financial Upgrades CVS Health (CVS) to Strong-Buy
www.americanbankingnews.com - January 8 at 12:44 AM
CVS Health (CVS) Upgraded to "Overweight" by Morgan StanleyCVS Health (CVS) Upgraded to "Overweight" by Morgan Stanley
www.americanbankingnews.com - January 6 at 11:10 PM
McKesson Completes Acquisition Of RxCrossroads From CVS Health For $735 MillionMcKesson Completes Acquisition Of RxCrossroads From CVS Health For $735 Million
www.benzinga.com - January 6 at 9:58 AM
CVS Health Breaks Above 200-Day Moving Average - Bullish for CVSCVS Health Breaks Above 200-Day Moving Average - Bullish for CVS
www.nasdaq.com - January 5 at 4:38 PM
CVS Stock Could Still Soar in 2018 After Rocket StartCVS Stock Could Still Soar in 2018 After Rocket Start
finance.yahoo.com - January 5 at 4:38 PM
Cramer's Stop Trading: CVS is the one to watchCramer's Stop Trading: CVS is the one to watch
finance.yahoo.com - January 5 at 4:38 PM
Aetna Acquisition Puts CVS Growth Prospects Back In Good HealthAetna Acquisition Puts CVS Growth Prospects Back In Good Health
www.msn.com - January 5 at 10:05 AM
CVS Health's (CVS) Outlook for 2018 Cheered by InvestorsCVS Health's (CVS) Outlook for 2018 Cheered by Investors
finance.yahoo.com - January 5 at 10:05 AM
CVS Health expects tax overhaul to boost cash flow, shares riseCVS Health expects tax overhaul to boost cash flow, shares rise
finance.yahoo.com - January 5 at 10:05 AM
CVS Health (CVS) Price Target Raised to $90.00CVS Health (CVS) Price Target Raised to $90.00
www.americanbankingnews.com - January 5 at 7:28 AM
CVS Health (CVS) Cut to "Hold" at VetrCVS Health (CVS) Cut to "Hold" at Vetr
www.americanbankingnews.com - January 5 at 12:40 AM
McKesson Buys RxCrossroads from CVS Health for $735 MillionMcKesson Buys RxCrossroads from CVS Health for $735 Million
www.zacks.com - January 4 at 4:55 PM
CVS, Walgreens Say Drug Prices Are Easing After Years of BallooningCVS, Walgreens Say Drug Prices Are Easing After Years of Ballooning
www.wsj.com - January 4 at 4:55 PM
UPDATE 1-CVS Health sees Q4 EPS at lower end of previous forecastUPDATE 1-CVS Health sees Q4 EPS at lower end of previous forecast
www.cnbc.com - January 4 at 9:55 AM

SEC Filings

CVS Health (NYSE:CVS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

CVS Health (NYSE:CVS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

CVS Health (NYSE CVS) Stock Chart for Friday, January, 19, 2018

Loading chart…

This page was last updated on 1/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.